ACQUIRED FACTOR-VIII INHIBITOR ASSOCIATED WITH CHRONIC INTERFERON-ALPHA THERAPY

被引：0
|
作者：
STRICKER, RB
BARLOGIE, B
KIPROV, DD
机构：
[1] CALIF PACIFIC MED CTR,DEPT MED,DIV IMMUNOTHERAPY,SAN FRANCISCO,CA
[2] UNIV ARKANSAS MED SCI HOSP,DIV HEMATOL ONCOL,LITTLE ROCK,AR
来源：
JOURNAL OF RHEUMATOLOGY | 1994年 / 21卷 / 02期
关键词：
FACTOR VIII INHIBITOR; INTERFERON; DRUG REACTION; MULTIPLE MYELOMA; BONE MARROW TRANSPLANTATION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Therapeutic use of interferon-alpha (IFN-alpha) has been associated with the development of a variety of autoimmune disorders. We describe a patient who received chronic treatment with IFN-alpha following autologous bone marrow transplantation for multiple myeloma. The patient developed an antibody inhibitor directed against factor VIII coagulant protein (FVIIIC) leading to a fatal hemorrhagic diathesis. The association between IFN-alpha therapy and autoimmune complications deserves wider recognition and further study.
引用
收藏
页码：350 / 352
页数：3
相关论文
共 50 条
  • [41] Differential expression of ISG20 in chronic hepatitis B patients and relation to interferon-alpha therapy response
    Lu, Xi
    Qin, Bo
    Ma, Qian
    Yang, Chun
    Gong, Xue-Yan
    Chen, Li-Min
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (09) : 1506 - 1512
  • [42] Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia
    Honda, K
    Ando, A
    Endo, M
    Shimizu, K
    Higashihara, M
    Nitta, K
    Nihei, H
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (01) : 123 - 130
  • [43] Dissecting the divergent effects of interferon-alpha on immune cells: Time to rethink combination therapy in chronic hepatitis B?
    Thimme, Robert
    Dandri, Maura
    JOURNAL OF HEPATOLOGY, 2013, 58 (02) : 205 - 209
  • [44] Two cases of transiently TSBAb-positive hypothyroidism induced by interferon-alpha therapy for chronic hepatitis C
    Hayakawa, T
    Nagai, Y
    Ohsawa, K
    Taniguchi, M
    Koike, N
    Notsumata, K
    Nakamura, S
    Ikeda, T
    Kobayashi, K
    ENDOCRINE JOURNAL, 1997, 44 (04) : 541 - 546
  • [45] Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C
    Tada, H
    Saitoh, S
    Nakagawa, Y
    Hirana, H
    Morimoto, M
    Shima, T
    Shimamoto, K
    Okanoue, T
    Kashima, K
    JOURNAL OF GASTROENTEROLOGY, 1996, 31 (04) : 582 - 584
  • [46] Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism
    MartinVivaldi, R
    Nogueras, F
    Gonzalez, A
    Quintero, D
    Pinel, LM
    Castro, T
    Hernandez, A
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1997, 89 (07) : 527 - 530
  • [47] Epidural placement in a patient with undiagnosed acquired haemophilia from factor VIII inhibitor
    Christie-Taylor, GA
    McAuliffe, GL
    ANAESTHESIA, 1999, 54 (04) : 367 - 371
  • [48] Effect of different incubation times on the detection of factor VIII inhibitor in acquired hemophilia A
    Zhang, Jiahong
    Mu, Runqing
    Chen, Junli
    Song, Jianqing
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (08) : E195 - E197
  • [49] Interferon-alpha in patients with chronic hepatitis C and normal transaminase levels.
    Salmerón, FJ
    Palacios, A
    Fernández-Piñar, CT
    Sánchez, MG
    Caballero, T
    Quintero, MD
    Ruiz-Extremera, A
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1999, 91 (10) : 679 - 683
  • [50] Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha
    Irani, Yazad D.
    Hughes, Amy
    Kok, Chung H.
    Clarson, Jade
    Yeung, David T.
    Ross, David M.
    Branford, Susan
    Hughes, Timothy P.
    Yong, Agnes S. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (06) : 1127 - 1136
12345